Acumen Wealth Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Acumen Wealth Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-920	Closed	-$28.9K	–	704
2026 Q2	$28.9K	Sell	920 -16	-2%	-$472	0.01%	202
2026 Q1	$23.2K	Hold	936	–	–	0.01%	206
2025 Q4	$21.8K	Buy	+936	New	+$20.8K	0.01%	208

Other funds holding CPRX

Teacher Retirement System of Texas Austin, Texas $37.3B AUM 26.21% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Acumen Wealth Advisors's CPRX Position: Q3 2026 in Review

Acumen Wealth Advisors sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 920 shares — an estimated $28.9K sold.

Acumen Wealth Advisors first reported a position in CPRX in Q4 2025 and held it in 3 quarters. The position peaked at $28.9K in Q2 2026. 3 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

Acumen Wealth Advisors reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
Acumen Wealth Advisors sold 920 Catalyst Pharmaceutical shares in Q3 2026, an estimated $28.9K.
Acumen Wealth Advisors first reported a position in Catalyst Pharmaceutical in Q4 2025 and held it in 3 quarters.
Acumen Wealth Advisors's Catalyst Pharmaceutical position peaked at $28.9K in Q2 2026.
3 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on Acumen Wealth Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.